Last reviewed · How we verify
NCT06766214
Attexis and tDCS for the Treatment of ADHD
NA trial testing transcranial direct current stimulation in ADHD in 30 participants. Completed in 24 February 2026.
21 November 2025
Quick facts
| Lead sponsor | University of Regensburg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 September 2024 |
| Primary completion | 21 November 2025 |
| Estimated completion | 24 February 2026 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- transcranial direct current stimulation
- sham transcranial direct current stimulation
Conditions studied
- ADHD — all drugs for ADHD →
Sponsor
University of Regensburg
Who can join
Adults 18 to 65, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized controlled two-arm study (RCT) will be conducted. It is planned to randomly assign eligible patients who receive a three-month access to the psychotherapeutic program (Attexis) to either an additional verum-tDCS or placebo-tDCS condition.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Home-based tDCS as an add-on to digital cognitive behavioral therapy application (dCBT app) in adults with ADHD: A sham-controlled randomized pilot study
Kerkel K, Reissmann A, Treml L, Schecklmann M, et al · · 2026 · DOI 10.64898/2026.05.21.26353771
Verify or expand the search:
- PubMed search for NCT06766214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcranial direct current stimulation
Trials testing the same drug.
- NCT07591194 — The Effects of Immersive Virtual Reality-Based Exergaming Combined With Transcranial Direct Current Stimulation on Execu · NA · not yet recruiting
- NCT07534397 — Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current · NA · not yet recruiting
- NCT06771531 — Brain Stimulation for Foot-sole Sensation in Older Adults With Foot-sole Somatosensory Deficits · NA · recruiting
- NCT07089056 — Effects of Transcranial Direct Current Stimulation After Short-term Immobilization on Motor Learning and Hand Function i · NA · not yet recruiting
- NCT06806267 — Study of the Effectiveness of VRET Combined With tDCS in the Treatment of PTSD in Ukrainian Veterans and Civilians · NA · recruiting
Other recruiting trials for ADHD
Currently open trials in the same condition.
- NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
- NCT07262853 — Dual Executive Function Training Package · NA · recruiting
- NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
- NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
- NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting
Other University of Regensburg trials
Trials by the same sponsor.
- NCT07444242 — Accelerated Treatment of Depressive Patients With tDCS · NA · not yet recruiting
- NCT06689592 — Mobile Transcranial Magnetic Stimulation · NA · completed
- NCT06520865 — TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis · completed
- NCT06212895 — Expectations of Patients Regarding Exercise in an Outpatient Clinic · unknown
- NCT05791812 — Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06766214 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Regensburg
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing